Cargando…
Safety Evaluation of Natural Drugs in Chronic Skeletal Disorders: A Literature Review of Clinical Trials in the Past 20 years
Chronic skeletal disorders (CSDs), including degenerative diseases such as osteoporosis (OP) and autoimmune disorders, have become a leading cause of disability in an ageing society, with natural drugs being indispensable therapeutic options. The clinical safety evaluation (CSE) of natural drugs in...
Autores principales: | Zhou, Dongyang, Zhang, Hao, Xue, Xu, Tao, Yali, Wang, Sicheng, Ren, Xiaoxiang, Su, Jiacan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793129/ https://www.ncbi.nlm.nih.gov/pubmed/35095508 http://dx.doi.org/10.3389/fphar.2021.801287 |
Ejemplares similares
-
Skeletal Muscle Na(+) Channel Disorders
por: Simkin, Dina, et al.
Publicado: (2011) -
Betaine Attenuates Osteoarthritis by Inhibiting Osteoclastogenesis and Angiogenesis in Subchondral Bone
por: Yajun, Wang, et al.
Publicado: (2021) -
Current Status and Trends in Peptide Receptor Radionuclide Therapy in the Past 20 Years (2000–2019): A Bibliometric Study
por: Lu, Xiaojing, et al.
Publicado: (2021) -
Stat3 Signaling Pathway: A Future Therapeutic Target for Bone-Related Diseases
por: Li, Jiadong, et al.
Publicado: (2022) -
Safety and Efficacy Analysis of Selinexor-Based Treatment in Multiple Myeloma, a Meta-Analysis Based on Prospective Clinical Trials
por: Tao, Yali, et al.
Publicado: (2021)